WCM
CLB icon

WealthTrak Capital Management’s Core Laboratories CLB Stock Holding History

WealthTrak Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25
Closed -$288 – 228
2025
Q2 		$288 Buy
+25
New +$297 ﹤0.01% 773

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

WealthTrak Capital Management's CLB Position: Q3 2025 in Review

WealthTrak Capital Management sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 25 shares — an estimated $288 sold.

WealthTrak Capital Management first reported a position in CLB in Q2 2025 and held it in 1 quarter. The position peaked at $288 in Q2 2025. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • WealthTrak Capital Management reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 25 Core Laboratories shares in Q3 2025, an estimated $288.
  • WealthTrak Capital Management first reported a position in Core Laboratories in Q2 2025 and held it in 1 quarter.
  • WealthTrak Capital Management's Core Laboratories position peaked at $288 in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.